KeyBanc lowered the firm’s price target on Acadia Healthcare (ACHC) to $30 from $35 and keeps an Overweight rating on the shares. The firm cites Q3 results, updated guidance, and conference call commentary.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Einhorn’s DME Capital bought PG&E and United Parks in Q3
- Acadia Healthcare price target lowered to $22 from $28 at RBC Capital
- Acadia Healthcare Settles $179M Securities Litigation
- Acadia Healthcare price target lowered to $27 from $29 at Guggenheim
- Acadia Healthcare’s Earnings Call: Mixed Sentiments and Strategic Moves